744 related articles for article (PubMed ID: 2338129)
1. Migration of stem cells and progenitors between marrow and spleen following thiamphenicol treatment of mice.
Goris H; Bungart B; Loeffler M; Schmitz S; Nijhof W
Exp Hematol; 1990 Jun; 18(5):400-7. PubMed ID: 2338129
[TBL] [Abstract][Full Text] [Related]
2. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
3. Hemopoiesis during thiamphenicol treatment. I. Stimulation of stem cells during eradication of intermediate cell stages.
Goris H; Loeffler M; Bungart B; Schmitz S; Nijhof W
Exp Hematol; 1989 Oct; 17(9):957-61. PubMed ID: 2776855
[TBL] [Abstract][Full Text] [Related]
4. Hemopoiesis during thiamphenicol treatment. II. A theoretical analysis shows consistency of new data with a previously hypothesized model of stem cell regulation.
Loeffler M; Bungart B; Goris H; Schmitz S; Nijhof W
Exp Hematol; 1989 Oct; 17(9):962-7. PubMed ID: 2776856
[TBL] [Abstract][Full Text] [Related]
5. Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia.
de Haan G; Loeffler M; Nijhof W
Exp Hematol; 1992 Jun; 20(5):600-4. PubMed ID: 1375161
[TBL] [Abstract][Full Text] [Related]
6. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
[TBL] [Abstract][Full Text] [Related]
7. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of L3T4+ cells on recovery from total-body irradiation.
Pantel K; Nakeff A
Exp Hematol; 1990 Sep; 18(8):863-7. PubMed ID: 1974863
[TBL] [Abstract][Full Text] [Related]
9. Hematopoiesis in the rat: quantitation of hematopoietic progenitors and the response to iron deficiency anemia.
Kimura H; Finch CA; Adamson JW
J Cell Physiol; 1986 Feb; 126(2):298-306. PubMed ID: 3944211
[TBL] [Abstract][Full Text] [Related]
10. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1.
Gallicchio VS; Shedlofsky SI; Swim AT; Robinson JM; Hulette BC; Messino MJ; Doukas MA
J Biol Response Mod; 1989 Aug; 8(4):422-39. PubMed ID: 2666587
[TBL] [Abstract][Full Text] [Related]
11. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
Mayani H; Guilbert LJ; Janowska-Wieczorek A
Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
[TBL] [Abstract][Full Text] [Related]
12. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
Gallicchio VS; Hughes NK; Tse KF
Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
[TBL] [Abstract][Full Text] [Related]
13. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
14. Age-related changes in various hemopoietic progenitor cells in senescence-accelerated (SAM-P) mice.
Tsuboi I; Morimoto K; Horie T; Mori KJ
Exp Hematol; 1991 Oct; 19(9):874-7. PubMed ID: 1893962
[TBL] [Abstract][Full Text] [Related]
15. Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells.
Jones RJ; Wagner JE; Celano P; Zicha MS; Sharkis SJ
Nature; 1990 Sep; 347(6289):188-9. PubMed ID: 2395470
[TBL] [Abstract][Full Text] [Related]
16. Leukopenia and altered hematopoietic activity in mice exposed to the abused inhalant, isobutyl nitrite.
Soderberg LS; Flick JT; Barnett JB
Exp Hematol; 1996 Jun; 24(7):848-53. PubMed ID: 8647236
[TBL] [Abstract][Full Text] [Related]
17. Hemopoietic effects of intravenous soluble glucan administration.
Patchen ML; MacVittie TJ
J Immunopharmacol; 1986; 8(3):407-25. PubMed ID: 3760593
[TBL] [Abstract][Full Text] [Related]
18. Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev).
Van Zant G; Shultz L
Exp Hematol; 1989 Feb; 17(2):81-7. PubMed ID: 2783574
[TBL] [Abstract][Full Text] [Related]
19. Effects of continuous stem cell factor administration on normal and erythropoietin-stimulated murine hemopoiesis: experimental results and model analysis.
de Haan G; Dontje B; Nijhof W; Loeffler M
Stem Cells; 1995 Jan; 13(1):65-76. PubMed ID: 7536513
[TBL] [Abstract][Full Text] [Related]
20. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
